Non Opioid Pain Patches Market

Non-Opioid Pain Patches Market by Types (Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, and Others), Distribution Channels (Hospitals, Online Pharmacies, and Drug Stores), and Regions (Asia Pacific, North America, Latin America, Europe and Middle East & Africa)- Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1823
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 58
  • No. Of Pages: 159
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global non-opioid pain patches market size was valued at USD 790.6 million in 2020 and is anticipated to expand at a CAGR of 4.5% during the forecast period, 2021-2028. The growth of the market is attributed to the increasing number of acute and chronic pain related disorders, along with the health benefits that the non-opioid pain patches provided to each patient.

Global Non Opioid Pain Patches Market Key Takeaways

Non-Opioid pain patches have been introduced in early 2018 when the World Health Organization or the WHO census report stated that a large amount of the population were committing to death for the relief of pain, or the management of pain has been handled very poorly across the globe. The Centre for Disease Control and Prevention along with the National Institute of Drug Abuse reported a disturbing census that over 90 Americans died of opioid overdose every day. The opioids were not legal and were largely made on non-directed or regulated laboratories and sold at high prices. The WHO announced the legality of non-opioid pain patches to be legal across the globe to remedy this situation. Non-Opioid pain patches has mainly found applications which require the relief of severe, acute and chronic pain in most of the internal systems of the patient. It is a class of medication which can send reliefs, as well as cure addictions to unhealthy habits such as smoking. The prescriptions given by the physicians for the use of non-opioid pain patches becomes critical for the dosage and minimal requirements need to be met for using these patches. Using non-opioid patches on healthy individuals could be counter-productive in the long run.

The COVID-19 pandemic has reduced the growth of the global non-opioid pain patches market. Researchers and scientists were not able to recognize the co-relation between the coronavirus and non-opioid pain patches. However, once the COVID-19 pandemic ends and when vaccinations reach the majority population of the globe, the non-opioid pain patches market is set to boost its growth to a double digit CAGR.

Market Trends, Drivers, Restraints, and Opportunities

  • Increase in occurrences of musculoskeletal disorders for which the pain can be alleviated by non-opioid pain patches is the primary reason for the projection of boosting the global market growth during the forecast period, 2021-2028.
  • Increase in the research and development activities leading to technological advancement of non-opioid pain patches presents a major factor boosting the market growth.
  • High prices for the development of non-opioid pain patches and high cost of services from the company’s perspective is anticipated to hinder the global non-opioid pain patches market growth. This becomes extremely difficult to function in developing countries such as India, South Africa and Brazil where there is limited healthcare infrastructure.
  • People have started exercising at gyms and fitness centres and there have been an increased consumption in multivitamins & nutritional supplements and thereby not reliant upon non-opioid pain patches. This can hinder the market growth.
  • R&D activities along with studies have shown that non-opioid pain patches can alleviate chronic pains in other internal systems apart from musculoskeletal.

Scope of the Report

The report on the global non-opioid pain patches market size includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Non-Opioid Pain Patches Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types (Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, and Others), and Distribution Channels (Hospitals, Online Pharmacies, and Drug Stores)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast

Key Players Covered in the Report

Richmar Inc; Acorda Therapeutics; Teva Pharmaceutical Industries Ltd; GlaxoSmithKline plc; Endo Pharmaceuticals Inc; Hisamitsu Pharmaceutical Co Inc; IBSA Institut Biochimque SA; Alkermes; Teikoku Seiyaku Co Ltd; Capsugel; and Mylan NV

Global Non-Opioid Pain Patches Market Segment Insights

Lidocaine patches segment is estimated to signify a large market share

Based on types, the global non-opioid pain patches market is segmented into lidocaine patches, diclofenac patches, methyl salicylate patches, capsaicin patches, ketoprofen patches, and others. The lidocaine patches segment is expected to constitute the major share of the market in 2019. These were the best patches available for the alleviant of pain, providing efficient drug delivery during the entire duration, and was available at low costs.

Meanwhile the diclofenac patches segment is anticipated to grow with a significant CAGR during the forecast period, 2021-2028. The safety profile of this class in patches was the highest and it also showed great signs of increasing efficacy rates. Researchers and scientists have focused more on diclofenac patches and believe they can even be effective to the patient’s neurological system.

Global Non Opioid Pain Patches Market Types

Hospitals segment is anticipated to register a huge market share

On the basis of distribution channels, the global non-opioid pain patches market is divided into hospitals, online pharmacies, and drug stores. The hospitals segment is expected to constitute the major share of the market in 2019. The major reason attributing to this market growth is the frequent number of patient visits and admissions for the treatment of pain, particularly the patients suffering from multiple musculoskeletal diseases and other disorders which can cause chronic and acute pain. There has been a long-term use of multiple painkillers which can usually bring an additional risk for medication-related adverse effects. This prompted physicians to prescribe oral drugs along with examinations from the hospitals, thereby increasing this segment market growth.

Meanwhile the online pharmacies segment is anticipated to grow with a significant CAGR during the forecast period, 2021-2028. The availability for the products present at online pharmacies can facilitate individuals for purchasing non-opioid patches for the alleviation chronic and acute pain. Now these patches can be procured without the need of a prescription, making users more convenient for purchasing from online pharmacies leading to the segment market growth.

North America is anticipated to dominate the market

On the basis of regions, the global non-opioid pain patches market is categorized as Asia Pacific, North America, Latin America, Europe and Middle East & Africa. The market in North America is expected to constitute a large share in 2019. This regional market growth can be attributed to the growing research & development expenditure along with the rising in adoption of the latest technology. The demand of non-opioid pain patches is increasing in this region due to the presence of the major market players in the market, an advantage other regions do not have. The cost of expenditure is significantly lower in North America than that of other economies. According to the American Chiropractic Association, the total expenditure spent by Americans for the treatment of back aches is USD 50 billion. Back pain along with upper respiratory infections are the most common disorders for which the patients visit their doctors. This results in therapies to combat the pain at minimum cost as the demand is huge. The non-opioid pain patches alleviates this pain, reduces the risk for various adverse effects, and will have a minute chance for being misused and ultimately leading to addiction, thereby increasing their demand to the highest compared to other regions.

However, the market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period, 2021-2028. There has been a sharp increase in the lifestyle-related disorders and with sedentary lifestyle, an increase in the patients suffering from acute and chronic pain became unavoidable. Major developers of the non-opioid patches, mainly multinational pharmaceutical companies along with the help of clinical research organizations or the CROs, have started making efforts to improve the healthcare supply chain to guarantee the availability of these patches in this region. Latin America is another region which has observed immense burden to patients suffering from back pain along with other musculoskeletal and cardiovascular disorders. This has slowly been added to the healthcare expenditures of this region. There has been an incremental increase in the patient count along with product adoption & cognizance which accelerated this regional market growth.

Global Non Opioid Pain Patches Market Regions

Segments

The global non-opioid pain patches market size has been segmented in terms of

Types
  • Lidocaine Patches
  • Diclofenac Patches
  • Methyl Salicylate Patches
  • Capsaicin Patches
  • Ketoprofen Patches
  • Others
Distribution Channels
  • Hospitals
  • Online Pharmacies
  • Drug Stores
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Richmar Inc
  • Acorda Therapeutics
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Endo Pharmaceuticals Inc
  • Hisamitsu Pharmaceutical Co Inc
  • IBSA Institut Biochimque SA
  • Alkermes
  • Teikoku Seiyaku Co Ltd
  • Capsugel
  • Mylan NV

Competitive Landscape

Major players competing in the global non-opioid pain patches market are Richmar Inc; Acorda Therapeutics; Teva Pharmaceutical Industries Ltd; GlaxoSmithKline plc; Endo Pharmaceuticals Inc; Hisamitsu Pharmaceutical Co Inc; IBSA Institut Biochimque SA; Alkermes; Teikoku Seiyaku Co Ltd; Capsugel; and Mylan NV. These market players are involved in several business strategies such as mergers, acquisitions partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. This market is widely fragmented to the point that numerous companies have been engaged to their own research and development studies to help the large global public from chronic pain. The market players have started using a large range of technologies for the development of products for the facilitation of prolonged drug releases for increasing product penetration and consumer base. This market is also very competitive with respect to being a comparatively new market opening an intense competition between new entrants and exiting players.

Key market players have started engaging in numerous mergers and acquisition activities for the expansion of their product profiles. Acorda Therapeutics confirmed the acquisition of NeurogesX in 2018, after testing their two developed products five years ago and this strengthened their neuropathic pain management portfolios. The acquired products were Phase Three-Stage Product NP-1998 and Qutenza which found applications in the treatment of diabetic neurotherapy and postherpetic neuralgia, respectively. The major market players also engaged in various collaborations with different distribution companies in order to increase in product penetration. Richmar Inc declared the complete distribution of the product LidoFlex Pain Relief patch across the globe in 2019 with the help of Scrip Companies group, suppliers of physical therapy equipment, chiropractic products & supplies.

Global Non Opioid Pain Patches Market Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Non Opioid Pain Patches Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Non Opioid Pain Patches Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Non Opioid Pain Patches Market - Supply Chain
  4.5. Global Non Opioid Pain Patches Market Forecast
     4.5.1. Non Opioid Pain Patches Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Non Opioid Pain Patches Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Non Opioid Pain Patches Market Absolute $ Opportunity
5. Global Non Opioid Pain Patches Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Non Opioid Pain Patches Market Size and Volume Forecast by Types
     5.3.1. Lidocaine Patches Diclofenac Patches Methyl Salicylate Patches Capsaicin Patches Ketoprofen Patches
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Non Opioid Pain Patches Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Non Opioid Pain Patches Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Non Opioid Pain Patches Demand Share Forecast, 2019-2026
7. North America Non Opioid Pain Patches Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Non Opioid Pain Patches Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Non Opioid Pain Patches Market Size and Volume Forecast by Types
     7.4.1. Lidocaine Patches Diclofenac Patches Methyl Salicylate Patches Capsaicin Patches Ketoprofen Patches
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Non Opioid Pain Patches Demand Share Forecast, 2019-2026
8. Latin America Non Opioid Pain Patches Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Non Opioid Pain Patches Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Non Opioid Pain Patches Market Size and Volume Forecast by Types
     8.4.1. Lidocaine Patches Diclofenac Patches Methyl Salicylate Patches Capsaicin Patches Ketoprofen Patches
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Non Opioid Pain Patches Demand Share Forecast, 2019-2026
9. Europe Non Opioid Pain Patches Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Non Opioid Pain Patches Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Non Opioid Pain Patches Market Size and Volume Forecast by Types
     9.4.1. Lidocaine Patches Diclofenac Patches Methyl Salicylate Patches Capsaicin Patches Ketoprofen Patches
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Non Opioid Pain Patches Demand Share Forecast, 2019-2026
10. Asia Pacific Non Opioid Pain Patches Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Non Opioid Pain Patches Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Non Opioid Pain Patches Market Size and Volume Forecast by Types
     10.4.1. Lidocaine Patches Diclofenac Patches Methyl Salicylate Patches Capsaicin Patches Ketoprofen Patches
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Non Opioid Pain Patches Demand Share Forecast, 2019-2026
11. Middle East & Africa Non Opioid Pain Patches Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Non Opioid Pain Patches Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Non Opioid Pain Patches Market Size and Volume Forecast by Types
     11.4.1. Lidocaine Patches Diclofenac Patches Methyl Salicylate Patches Capsaicin Patches Ketoprofen Patches
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Non Opioid Pain Patches Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Non Opioid Pain Patches Market: Market Share Analysis
  12.2. Non Opioid Pain Patches Distributors and Customers
  12.3. Non Opioid Pain Patches Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Richmar Inc Acorda Therapeutics Teva Pharmaceutical Industries Ltd GlaxoSmithKline plc Endo Pharmaceuticals Inc
The global non-opioid pain patches market size has been segmented in terms of

Types
  • Lidocaine Patches
  • Diclofenac Patches
  • Methyl Salicylate Patches
  • Capsaicin Patches
  • Ketoprofen Patches
  • Others
Distribution Channels
  • Hospitals
  • Online Pharmacies
  • Drug Stores
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Richmar Inc
  • Acorda Therapeutics
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc
  • Endo Pharmaceuticals Inc
  • Hisamitsu Pharmaceutical Co Inc
  • IBSA Institut Biochimque SA
  • Alkermes
  • Teikoku Seiyaku Co Ltd
  • Capsugel
  • Mylan NV

Major players competing in the global non-opioid pain patches market are Richmar Inc; Acorda Therapeutics; Teva Pharmaceutical Industries Ltd; GlaxoSmithKline plc; Endo Pharmaceuticals Inc; Hisamitsu Pharmaceutical Co Inc; IBSA Institut Biochimque SA; Alkermes; Teikoku Seiyaku Co Ltd; Capsugel; and Mylan NV. These market players are involved in several business strategies such as mergers, acquisitions partnerships, collaborations, capacity expansion, and product launches to enhance their market shares. This market is widely fragmented to the point that numerous companies have been engaged to their own research and development studies to help the large global public from chronic pain. The market players have started using a large range of technologies for the development of products for the facilitation of prolonged drug releases for increasing product penetration and consumer base. This market is also very competitive with respect to being a comparatively new market opening an intense competition between new entrants and exiting players.

Key market players have started engaging in numerous mergers and acquisition activities for the expansion of their product profiles. Acorda Therapeutics confirmed the acquisition of NeurogesX in 2018, after testing their two developed products five years ago and this strengthened their neuropathic pain management portfolios. The acquired products were Phase Three-Stage Product NP-1998 and Qutenza which found applications in the treatment of diabetic neurotherapy and postherpetic neuralgia, respectively. The major market players also engaged in various collaborations with different distribution companies in order to increase in product penetration. Richmar Inc declared the complete distribution of the product LidoFlex Pain Relief patch across the globe in 2019 with the help of Scrip Companies group, suppliers of physical therapy equipment, chiropractic products & supplies.

Global Non Opioid Pain Patches Market Key Players

Buy Report